AIP
BNTC icon

Ameritas Investment Partners’s Benitec Biopharma BNTC Stock Holding History

Ameritas Investment Partners’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Hold
1,477
– – ﹤0.01% 2706
2025
Q4 		$19.9K Hold
1,477
– – ﹤0.01% 2646
2025
Q3 		$20.7K Hold
1,477
– – ﹤0.01% 2645
2025
Q2 		$17.3K Buy
+1,477
New +$20.7K ﹤0.01% 2722

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameritas Investment Partners's BNTC Position: Q1 2026 in Review

Ameritas Investment Partners held its Benitec Biopharma (BNTC) position steady in Q1 2026 at 1,477 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

Ameritas Investment Partners first reported a position in BNTC in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.7K in Q3 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Ameritas Investment Partners held 1,477 shares of Benitec Biopharma worth $15.7K as of Q1 2026.
  • Ameritas Investment Partners left its Benitec Biopharma share count unchanged in Q1 2026.
  • Benitec Biopharma made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2706 holding.
  • Ameritas Investment Partners first reported a position in Benitec Biopharma in Q2 2025 and has held it in 4 quarters since.
  • Ameritas Investment Partners's Benitec Biopharma position peaked at $20.7K in Q3 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.